These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34662881)

  • 1. Soluble Endoglin and Uterine Artery Flow Doppler Ultrasonography as Markers of Progression to Preeclampsia in Women with Gestational Hypertension.
    Molina Pérez CJ; Nolasco Leaños AG; Carrillo Juárez RI; Berumen Lechuga MG; Isordia Salas I; Leaños Miranda A
    Gynecol Obstet Invest; 2021; 86(5):445-453. PubMed ID: 34662881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second trimester uterine artery Doppler screening in prediction of adverse pregnancy outcome in high risk women.
    Pongrojpaw D; Chanthasenanont A; Nanthakomon T
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S127-30. PubMed ID: 21294407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of placental growth factor and uterine artery doppler pulsatility index in pregnancies involving intrauterine fetal growth restriction or preeclampsia to predict perinatal outcomes.
    Gomez-Roig MD; Mazarico E; Sabria J; Parra J; Oton L; Vela A
    Gynecol Obstet Invest; 2015; 80(2):99-105. PubMed ID: 25924544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.
    Tay J; Masini G; McEniery CM; Giussani DA; Shaw CJ; Wilkinson IB; Bennett PR; Lees CC
    Am J Obstet Gynecol; 2019 Jan; 220(1):96.e1-96.e8. PubMed ID: 30243605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population.
    Hafner E; Metzenbauer M; Höfinger D; Stonek F; Schuchter K; Waldhör T; Philipp K
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):652-7. PubMed ID: 16514618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third trimester uterine artery Doppler indices as predictors of preeclampsia and neonatal small for gestational age.
    Običan SG; Odibo L; Tuuli MG; Rodriguez A; Odibo AO
    J Matern Fetal Neonatal Med; 2020 Oct; 33(20):3484-3489. PubMed ID: 30760063
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
    Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
    Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension?
    Espinoza J; Kusanovic JP; Bahado-Singh R; Gervasi MT; Romero R; Lee W; Vaisbuch E; Mazaki-Tovi S; Mittal P; Gotsch F; Erez O; Gomez R; Yeo L; Hassan SS
    J Ultrasound Med; 2010 Jul; 29(7):1103-15. PubMed ID: 20587434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-end arteriolar resistance limits uterine artery blood flow and restricts fetal growth in preeclampsia and gestational hypertension at high altitude.
    Browne VA; Toledo-Jaldin L; Davila RD; Lopez LP; Yamashiro H; Cioffi-Ragan D; Julian CG; Wilson MJ; Bigham AW; Shriver MD; Honigman B; Vargas E; Roach R; Moore LG
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1221-9. PubMed ID: 21325643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.
    Papageorghiou AT; Yu CK; Bindra R; Pandis G; Nicolaides KH;
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):441-9. PubMed ID: 11844162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Predictive Model at 11
    Chang Y; Chen X; Cui HY; Li X; Xu YL
    Reprod Sci; 2017 May; 24(5):783-789. PubMed ID: 27678097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating angiogenic factors are associated with progression to preeclampsia and the occurrence of adverse outcomes in women with gestational hypertension.
    Nolasco-Leaños AG; Ramírez-Valenzuela KL; Carrillo-Juárez RI; Molina-Pérez CJ; Isordia-Salas I; Leaños-Miranda A
    J Hypertens; 2021 Mar; 39(3):573-580. PubMed ID: 33149103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum YKL-40 and uterine artery Doppler -- a prospective cohort study, with focus on preeclampsia and small-for-gestational-age.
    Gybel-Brask D; Høgdall E; Johansen J; Christensen IJ; Skibsted L
    Acta Obstet Gynecol Scand; 2014 Aug; 93(8):817-24. PubMed ID: 24861484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of perinatal outcome by combination of first trimester maternal plasma homocysteine with uterine artery Doppler velocimetry.
    Kaymaz C; Demir A; Bige O; Cagliyan E; Cimrin D; Demir N
    Prenat Diagn; 2011 Dec; 31(13):1246-50. PubMed ID: 22120509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.